In a clinical study, Ramos et al (74) showed that the combination of immunotherapy and chemotherapy can overcome immunosuppression, reduce the accumulation of immunosuppressive cells, enhance the frequencies of antigen-presenting cell/CD8+ T cells, and boost anti-tumor immunity. Here, CD8A is linked to neoplasm.